Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Pharmacodynamic and pharmacogenomic study of the nanoparticle conjugate of camptothecin CRLX101 for the treatment of cancer.

Gaur S, Wang Y, Kretzner L, Chen L, Yen T, Wu X, Yuan YC, Davis M, Yen Y.

Nanomedicine. 2014 Oct;10(7):1477-86. doi: 10.1016/j.nano.2014.04.003. Epub 2014 Apr 22.

PMID:
24768630
2.

Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels.

Kretzner L, Scuto A, Dino PM, Kowolik CM, Wu J, Ventura P, Jove R, Forman SJ, Yen Y, Kirschbaum MH.

Cancer Res. 2011 Jun 1;71(11):3912-20. doi: 10.1158/0008-5472.CAN-10-2259. Epub 2011 Apr 18.

3.

The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival.

Scuto A, Krejci P, Popplewell L, Wu J, Wang Y, Kujawski M, Kowolik C, Xin H, Chen L, Wang Y, Kretzner L, Yu H, Wilcox WR, Yen Y, Forman S, Jove R.

Leukemia. 2011 Mar;25(3):538-50. doi: 10.1038/leu.2010.289. Epub 2010 Dec 17.

4.

Human non-CG methylation: are human stem cells plant-like?

Dyachenko OV, Schevchuk TV, Kretzner L, Buryanov YI, Smith SS.

Epigenetics. 2010 Oct 1;5(7):569-72. Epub 2010 Oct 1. Review.

5.

Preclinical results of camptothecin-polymer conjugate (IT-101) in multiple human lymphoma xenograft models.

Numbenjapon T, Wang J, Colcher D, Schluep T, Davis ME, Duringer J, Kretzner L, Yen Y, Forman SJ, Raubitschek A.

Clin Cancer Res. 2009 Jul 1;15(13):4365-73. doi: 10.1158/1078-0432.CCR-08-2619. Epub 2009 Jun 23.

6.

The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells.

Scuto A, Kirschbaum M, Kowolik C, Kretzner L, Juhasz A, Atadja P, Pullarkat V, Bhatia R, Forman S, Yen Y, Jove R.

Blood. 2008 May 15;111(10):5093-100. doi: 10.1182/blood-2007-10-117762. Epub 2008 Mar 18.

7.

Transgene-induced CCWGG methylation does not alter CG methylation patterning in human kidney cells.

Shevchuk T, Kretzner L, Munson K, Axume J, Clark J, Dyachenko OV, Caudill M, Buryanov Y, Smith SS.

Nucleic Acids Res. 2005 Oct 24;33(19):6124-36. Print 2005.

8.

Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results.

Crocitto LE, Korns D, Kretzner L, Shevchuk T, Blair SL, Wilson TG, Ramin SA, Kawachi MH, Smith SS.

Urology. 2004 Oct;64(4):821-5.

PMID:
15491741
9.
11.

Use of microfluidics chips for the detection of human telomerase RNA.

Fuller RA, Clark J, Kretzner L, Korns D, Blair SL, Crocitto LE, Smith SS.

Anal Biochem. 2003 Feb 15;313(2):331-4. No abstract available.

PMID:
12605872
12.

Novel expression patterns of the myc/max/mad transcription factor network in developing murine prostate gland.

Luo Q, Harmon E, Timms BG, Kretzner L.

J Urol. 2001 Sep;166(3):1071-7.

PMID:
11490301
13.

Characterization of the chicken CTCF genomic locus, and initial study of the cell cycle-regulated promoter of the gene.

Klenova EM, Fagerlie S, Filippova GN, Kretzner L, Goodwin GH, Loring G, Neiman PE, Lobanenkov VV.

J Biol Chem. 1998 Oct 9;273(41):26571-9.

14.

Functional analysis of the AUG- and CUG-initiated forms of the c-Myc protein.

Blackwood EM, Lugo TG, Kretzner L, King MW, Street AJ, Witte ON, Eisenman RN.

Mol Biol Cell. 1994 May;5(5):597-609.

15.

Binding of myc proteins to canonical and noncanonical DNA sequences.

Blackwell TK, Huang J, Ma A, Kretzner L, Alt FW, Eisenman RN, Weintraub H.

Mol Cell Biol. 1993 Sep;13(9):5216-24.

16.

Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.

Ayer DE, Kretzner L, Eisenman RN.

Cell. 1993 Jan 29;72(2):211-22.

PMID:
8425218
17.

Myc and Max proteins possess distinct transcriptional activities.

Kretzner L, Blackwood EM, Eisenman RN.

Nature. 1992 Oct 1;359(6394):426-9.

PMID:
1406956
18.

Myc and Max function as a nucleoprotein complex.

Blackwood EM, Kretzner L, Eisenman RN.

Curr Opin Genet Dev. 1992 Apr;2(2):227-35. Review.

PMID:
1638116
19.

Transcriptional activities of the Myc and Max proteins in mammalian cells.

Kretzner L, Blackwood EM, Eisenman RN.

Curr Top Microbiol Immunol. 1992;182:435-43.

PMID:
1490382
20.

The Myc:Max protein complex and cell growth regulation.

Blackwood EM, Lüscher B, Kretzner L, Eisenman RN.

Cold Spring Harb Symp Quant Biol. 1991;56:109-17. Review. No abstract available.

PMID:
1819481
21.

Sequence-specific DNA binding by the c-Myc protein.

Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN, Weintraub H.

Science. 1990 Nov 23;250(4984):1149-51.

PMID:
2251503
22.
23.
24.

Contribution of U1 snRNA structural domains to U1 snRNP function.

Liao XL, Kretzner L, Seraphin B, Rosbash M.

Mol Biol Rep. 1990;14(2-3):143. No abstract available.

PMID:
2141898
26.

S. cerevisiae U1 RNA is large and has limited primary sequence homology to metazoan U1 snRNA.

Kretzner L, Rymond BC, Rosbash M.

Cell. 1987 Aug 14;50(4):593-602.

PMID:
2440584

Supplemental Content

Loading ...
Support Center